Does LENALIDOMIDE Cause Malignant transformation? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant transformation have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
10
Reports of Malignant transformation with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
10
Deaths
0
Hospitalizations
How Dangerous Is Malignant transformation From LENALIDOMIDE?
Of the 10 reports, 10 (100.0%) resulted in death.
Is Malignant transformation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Malignant transformation?
OSIMERTINIB (109)
ETOPOSIDE (108)
MELPHALAN (95)
CYTARABINE (91)
CARMUSTINE (88)
CYCLOPHOSPHAMIDE (73)
PREDNISONE (69)
GEFITINIB (67)
VINCRISTINE (66)
DOXORUBICIN (61)
Which LENALIDOMIDE Alternatives Have Lower Malignant transformation Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE